Bevacizumab: all 1,786 studies that test it
Page 14 of 18. Open to participants first (285), then studies with results posted, then the rest; newest registration first within each.
- Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)Status unknownNCT01635803Phase 2/3
- Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)Status unknownNCT01635790Phase 2/3
- A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT01633970Phase 1
- Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver MetsCompletedNCT01632722Phase 2
- CRLX101 Plus Bevacizumab in Advanced RCCCompletedNCT01625936Phase 1
- Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung CancerStatus unknownNCT01623102Phase 2
- Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular EdemaCompletedNCT01572350Phase 3
- Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer PatientsCompletedNCT01554059Phase 2
- Perioperative Treatment of Resectable Liver MetastasesWithdrawnNCT01540435Phase 2
- Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal CancerActive, not recruitingNCT01531595Phase 2
- Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First RecurrenceTerminatedNCT01526837Phase 1
- Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid TumorsCompletedNCT01514123Phase 1
- Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver MetastasesTerminatedNCT01508000Phase 2
- The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic TelangiectasiaCompletedNCT01507480Phase 1
- Effect of the Adjunctive IVB Before PRPCompletedNCT01504724Phase 4
- Efficacy and Safety Study of Avastin to Treat Neovascularisation of the CorneaCompletedNCT01501760Phase 3
- A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung CancerCompletedNCT01496742Phase 2
- Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung CancerCompletedNCT01493843Phase 2
- Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular EdemaStatus unknownNCT01487629Phase 2
- Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular DegenerationCompletedNCT01473251Not applicable
- Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric CancerCompletedNCT01471470Phase 2
- Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT01459380Phase 1
- Dasatinib in Combination With Bevacizumab to Treat Advanced Solid TumorsCompletedNCT01445509Phase 1
- Avastin Plus Radiotherapy in Elderly Patients With GlioblastomaCompletedNCT01443676Phase 2
- Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With BevacizumabCompletedNCT01442649Phase 2
- A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.WithdrawnNCT01441388Phase 1
- Acute Changes in Intraocular Cytokines After Intravitreal BevacizumabStatus unknownNCT01439178Not applicable
- Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma MultiformeCompletedNCT01435395Phase 1
- Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein OcclusionCompletedNCT01428388Not applicable
- DCE-MRI PET Bevacizumab Study in Rectal CancerWithdrawnNCT01426074Phase 2
- Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic RetinopathyStatus unknownNCT01422018Not applicable
- 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal CancerCompletedNCT01417494Phase 2
- Therapeutic Study of Bevacizumab Injection Directly Inside the Keloid TissueTerminatedNCT01408953Phase 2
- Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic AstrocytomaSuspendedNCT01386710Phase 1/2
- Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerCompletedNCT01383343Phase 1
- Intralesional Bevacizumab Injection on Primary PterygiumStatus unknownNCT01380678Phase 3
- Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)CompletedNCT01368848Phase 2
- A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast CancerCompletedNCT01367028Phase 2
- A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous ChemotherapyCompletedNCT01364012Phase 3
- Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2
- Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain MetastasisCompletedNCT01332929Phase 1
- GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid TumorsCompletedNCT01332604Phase 1
- Optic Neuropathy in 10 Patients With Glioblastoma Receiving BevacizumabWithdrawnNCT01331616Early Phase 1
- Comparison of Intravitreal Bevacizumab and Triamcinolone With PlaceboStatus unknownNCT01330524Phase 1/2
- Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)CompletedNCT01327222Phase 3
- Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal CancerCompletedNCT01321957Phase 2
- Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast CancerStatus unknownNCT01321775Phase 2
- Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01314274Phase 2
- Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)WithdrawnNCT01314066Phase 2
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian CancerTerminatedNCT01312376Phase 1
- A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent GlioblastomaCompletedNCT01308684Phase 1
- Bevacizumab for Neovascular Age-related Macular DegenerationCompletedNCT01306591Not applicable
- Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced AngiosarcomasCompletedNCT01303497Phase 2
- A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid TumorsCompletedNCT01301716Phase 1
- Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01298076Phase 2
- IXO+A in mCRC With Liver-only MetastasesWithdrawnNCT01293942Phase 2
- Bevacizumab and Lomustine for Recurrent GBMCompletedNCT01290939Phase 3
- Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent PterygiumCompletedNCT01288404Not applicable
- Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell CarcinomaCompletedNCT01283048Phase 1
- Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal MetastasisCompletedNCT01281696Phase 2
- Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal CancerCompletedNCT01274624Phase 1
- Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney CancerStatus unknownNCT01274273Phase 2
- Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal CancerTerminatedNCT01271166Phase 1
- Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell CarcinomaTerminatedNCT01264341Phase 2
- Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy OutcomeCompletedNCT01263834Phase 2/3
- Pilot Study for Locally Advanced Head and Neck CancerWithdrawnNCT01262859Phase 2
- Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMDWithdrawnNCT01256580Not applicable
- Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT01254526Phase 1
- EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid TumorsCompletedNCT01251926Phase 1
- Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal CancerStatus unknownNCT01249521Phase 2
- Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid MalignanciesCompletedNCT01243359Phase 1
- Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)WithdrawnNCT01232777Phase 2
- Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.CompletedNCT01229813Phase 3
- Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy SurgeryWithdrawnNCT01229202Phase 4
- Study of Intraperitoneal Carboplatin with IV Paclitaxel and Bevacizumab in Untreated Ovarian CancerCompletedNCT01220154Phase 1
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialActive, not recruitingNCT01217931Phase 2
- Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the EyeStatus unknownNCT01217398Phase 2
- Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without BevacizumabCompletedNCT01213238Phase 1
- Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast CancerCompletedNCT01208480Phase 2
- FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal CancerCompletedNCT01206530Phase 1/2
- Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS MutationsCompletedNCT01206049Phase 2
- Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT01205022Phase 1
- Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine TumorsStatus unknownNCT01203306Phase 2
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian CancerTerminatedNCT01202890Phase 1
- A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast CancerTerminatedNCT01200212Phase 3
- Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal CancersCompletedNCT01200121Phase 2
- Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceCompletedNCT01197170Phase 1
- Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid TumorsCompletedNCT01193595Phase 1
- Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast CancerCompletedNCT01190345Phase 2
- Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast CancerCompletedNCT01186991Phase 2
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
- A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer PatientsCompletedNCT01183494Phase 1
- French Evaluation Group Avastin Versus LucentisCompletedNCT01170767Phase 3
- Bevacizumab in Recurrent Grade II and III GliomaCompletedNCT01164189Phase 2
- First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal CancerCompletedNCT01163396Phase 2
- Molecular Triaging of Newly Diagnosed Breast CancerWithdrawnNCT01159236Not applicable
- A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)WithdrawnNCT01156961Phase 4
- Bendamustine and Bevacizumab for Advanced CancersCompletedNCT01152203Phase 1
- Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01149850Phase 2
- Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant GliomaStatus unknownNCT01144988Phase 2